Current stock page

Catalysts

CI Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareMedical - Healthcare PlansScore data as of Oct 21, 2026

CICigna Corporation

Healthcare / Medical - Healthcare Plans

Relative Leader / Watch

Strong Relative Position

NeutralEdge 8/10
$304.37−$2.23 (−0.73%)

Latest quote

  • Momentum
    84
  • Value
    72
  • Quality
    39
  • Risk resilience
    51
  • Sentiment
    —
algovestiq.comScore data as of Oct 21, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Nov 5, 2026

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 62/100

Momentum 84/100 and sentiment — before the next covered event.

Recent coverage
5 articles

Updated Oct 21, 2026 · Sentiment 36.32%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 84/100AIQ Edge 8/10 Strong Relative Position
Beat rate
100%
4 of 4 reported periods
Average surprise
+2.5%
Across covered historical reports
Latest result
+2.4%
Jul 30, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Oct 29, 2026—$7.46——$72.65B—
Jul 30, 2026—$7.60$7.78+2.4%$70.14B$71.67B
Apr 30, 2026—$7.60$7.79+2.5%$66.29B$68.49B
Feb 5, 2026—$7.88$8.08+2.5%$70.31B$72.47B
Oct 30, 2025—$7.64$7.83+2.5%$67.58B$69.75B

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
18
Buy
6
Hold
12-month analyst target
$342.37
+12.48% versus current price
Based on 13 analyst observations. Targets are estimates, not predictions.
Low target
$302.00
-0.78% vs latest price
Average target
$342.37
+12.48% vs latest price
High target
$400.00
+31.42% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateNov 5, 2026

Next known earnings or reporting date.

EPS estimate$7.52

Current analyst expectation for the upcoming report.

Revenue estimate$72.64B

Current analyst expectation for the upcoming report.

Sentiment score—

News pressure around the setup.

Momentum score84

Where event reaction would show up first.

AIQ score62/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
13
Average target
$342.37
Target upside
12.48%
Target range
$302.00 - $400.00
90-day revisions
1

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
4
Neutral
1
Negative
0
insidermonkey.com · Oct 9, 2026

CVS Health (CVS) vs Cigna (CI): Which is a Better Stock to Buy?

CVS Health Corporation (NYSE:CVS) traded at around $88 on October 7, up 1.76% on the day and 12.63% higher over twelve months.

seekingalpha.com · Oct 1, 2026

Cigna: Deeply Undervalued With Double-Digit EPS Growth Ahead (NYSE:CI)

Cigna is rated a 'Strong Buy' for its compelling value, robust earnings growth, and capital returns at a forward P/E of 8.9x. Learn more about CI stock here.

seekingalpha.com · Sep 30, 2026

The Cigna Group (CI) Analyst/Investor Day - Slideshow (NYSE:CI) 2026-09-30

2026-09-30. The following slide deck was published by The Cigna Group in conjunction with this event.

gurufocus.com · Sep 30, 2026

Cigna (CI) Unveils $3 Billion AI Initiative, Reaffirms 2026 Guidance Amid Strong Dividend Profile

On September 30, 2026, Cigna (NYSE: CI) announced a $3 billion multi-year investment plan focused on enhancing performance through artificial intelligence and p

gurufocus.com · Sep 22, 2026

CI Looks 30.3% Undervalued on GF Value™

On September 22, 2026, the Centers for Medicare & Medicaid Services (CMS) announced decisive actions to cancel approximately 315,000 unauthorized enrollments in

Open full news and sentiment

CI Catalysts FAQ

What are the next catalysts for CI stock?

CI's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move CI stock?

Upcoming events that could move CI include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could CI's next earnings report affect the stock?

CI's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive CI stock higher?

CI could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt CI stock?

CI could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.